When:
Thursday, November 9, 2023
11:00 AM - 12:00 PM CT
Where: Online
Audience: Faculty/Staff - Student - Post Docs/Docs - Graduate Students
Contact:
Sonia Kim
(847) 467-0446
Group: Innovation and New Ventures Office
Category: Other
As most of you know, Osage University Partners (OUP) has accumulated a comprehensive database of de-identified license agreements from several of our partner institutions. The goal of the database is to generate meaningful and granular sector dashboards and curated data sets of comparable deal terms to facilitate startup license negotiations and confirm fair market value for transactions. With over 2,600 startup licenses in the database from 2009-present, there is a unique opportunity to analyze these data and provide statistics on overall and sector-specific licensing trends over time.
For our 2023 License Lowdown webinar, we’ll explore how non-financial factors may affect the startup license financial terms within the database. If a startup was funded at the time the license was signed, would that increase or decrease the monetary value of the license? What if a faculty member is tenured and a repeat entrepreneur? Or the university has provided additional resources to the startup? Join Jaimie Testai of OUP for a webinar that will analyze whether these additional data points collected for the database affect the financials in startup licenses. Some examples of non-financial information that is collected from our partner universities are funding status of the company, information about the academic founder, patent reimbursement, resources provided by the university, and other license-specific information.
Speaker Bio:
Jaimie Testai joined OUP in 2019, where her role is to examine best practices in licensing and entrepreneurial development across our university partners to develop content for dissemination. Jaimie is an alumnus of Rutgers University where she obtained her Masters of Biomedical Science in 2013. Before earning her graduate degree, Jaimie worked as a research scientist investigating stem cell applications in stroke and traumatic brain injury models. She left laboratory work in 2014 to pursue work in research development at Rutgers School of Dental Medicine where she grew the School’s predoctoral student research program by 150% over a 2 year period. Before she left Rutgers, Jaimie was Senior Manager at the Center for Corporate Engagement, where she facilitated industry engagements across Rutgers’ Newark, New Brunswick and Camden locations, serving as the primary point of contact among companies in the biopharmaceutical and medical device industry sectors.